Position in LENZ
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$127,267
-$255,469 QoQ
Shares Held
13,909
-41.9% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LENZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HARBOR CAPITAL ADVISORS, INC. holds $23,126,231 across 27 Biotechnology names. LENZ ranks #22 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
33,948 | $2,827,528 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
30,353 | $2,639,800 | |
| 3 | TARS |
Tarsus Pharmaceuticals, Inc.
|
29,283 | $2,054,202 | |
| 4 | VCEL |
Vericel Corp
|
63,718 | $2,049,808 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
31,355 | $2,026,473 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
83,196 | $1,742,956 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
80,085 | $1,742,649 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
43,005 | $1,454,859 |
All Filings in LENZ
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $127,267 | 13,909 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $382,736 | 23,921 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $680,300 | 14,605 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,466,701 | 50,041 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,249,917 | 48,616 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,269,962 | 43,989 | Shares | Sole | 2025-01-10 | |
| No filing history on record for this holder in this stock. | ||||||